1. Home
  2. GNSS vs XBIT Comparison

GNSS vs XBIT Comparison

Compare GNSS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

N/A

Current Price

$1.44

Market Cap

60.1M

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.97

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GNSS
XBIT
Founded
1992
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Pharmaceuticals and Biotechnology
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.1M
57.6M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
GNSS
XBIT
Price
$1.44
$1.97
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $3.87
N/A
AVG Volume (30 Days)
★ 87.3K
84.9K
Earning Date
12-15-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.44
N/A
EPS
★ N/A
N/A
Revenue
★ $26,306,790.00
N/A
Revenue This Year
$39.82
N/A
Revenue Next Year
$12.95
$30.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 29.50
N/A
52 Week Low
$1.17
$1.80
52 Week High
$2.43
$2.73

Technical Indicators

Market Signals
Indicator
GNSS
XBIT
Relative Strength Index (RSI) 48.77 45.36
Support Level $1.40 $1.83
Resistance Level $1.64 $2.42
Average True Range (ATR) 0.13 0.11
MACD -0.01 0.01
Stochastic Oscillator 35.56 45.45

Price Performance

Historical Comparison
GNSS
XBIT

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: